PT  - JOURNAL ARTICLE
AU  - John R. Bartholomew
TI  - Update on the management of venous thromboembolism
AID  - 10.3949/ccjm.84.s3.04
DP  - 2017 Dec 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 39--46
VI  - 84
IP  - 12 suppl 3
4099  - http://www.ccjm.org/content/84/12_suppl_3/39.short
4100  - http://www.ccjm.org/content/84/12_suppl_3/39.full
SO  - Cleve Clin J Med2017 Dec 01; 84
AB  - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common cardiovascular disease associated with significant morbidity ranging from painful leg swelling, chest pain, shortness of breath, and even death. Long-term complications include recurrent VTE, postpulmonary embolism syndrome, chronic thromboembolic pulmonary hypertension, and postthrombotic syndrome (PTS). Management of VTE requires immediate anticoagulation therapy based on a risk assessment for bleeding. Direct oral anticoagulants (DOACs) have become an important option for patients as reflected in the most recent American College of Chest Physician treatment guidelines.